Takeda Pharmaceutical Company Limited (TAK)
NYQ – Real Time Price. Currency in USD
15.91
+0.26 (1.66%)
At close: Jun 26, 2026, 4:00 PM EDT
15.91
0.00 (0.00%)
After-hours: Jun 26, 2026, 6:19 PM EDT
Find any stock by ticker or company name

NYQ – Real Time Price. Currency in USD
15.91
+0.26 (1.66%)
At close: Jun 26, 2026, 4:00 PM EDT
15.91
0.00 (0.00%)
After-hours: Jun 26, 2026, 6:19 PM EDT
No Data
There are no news for this stock.
Total debt $34.4B significantly exceeds cash reserves ($909.9M), raising financial stability concerns
Total current assets $19.4B exceed Total current liabilities $17.8B, highlighting excellent liquidity
Debt-to-equity ratio (0.7) is well below the industry average (-0.8), showcasing prudent financial management
Interest coverage ratio (4x) indicates the company easily manages its debt payments
Negative free cash flow -$162.8M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.09 | 2.52 | 7.0 | |
| Quick ratio | 0.60 | 1.78 | 4.0 | |
| Debt to Equity | 0.74 | -0.80 | 7.0 | |
| Debt to Assets | 0.35 | 0.73 | 6.0 | |
| Interest coverage | 3.63 | -13.90 | 9.0 | |
| Weighted average score | 6.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 29.73B | 29.52B | 30.05B | 29.90B | 29.91B |
| Gross Profit | 16.97B | 16.10B | 16.10B | 16.17B | 15.99B |
| Operating Income | 4.86B | 3.68B | 4.12B | 4.20B | 4.33B |
| Net Income | 2.34B | 998M | 708M | -1.01B | -896M |
| EBITDA | 9.76B | 8.72B | 9.11B | 8.99B | 9.26B |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -2.16 | -37.89 | 1.0 |
| Next quarter | 0.02 | 664.25 | 6.0 |
| Current year | 1.87 | -4.43 | 2.0 |
| Next year | 1.61 | 64.89 | 6.5 |
| Weighted average score | 3.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -9.8 | -449.12 | -123.08 | -108.03 | 1.0 |
| Y/Y | 0.93 | -246.96 | 78.38 | -118.02 | 3.5 |
| 3y average | 0.2 | -109.73 | -5.74 | 5.24 | 2.3 |
| 5y average | -0.08 | -71.42 | -6.72 | -1.88 | 1.0 |
| Weighted average score | 2.0 | ||||
Negative projected free cash flow
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 4.46 | 4.46 | 9.0 |
| Payout ratio | 0.15 | 0.15 | 2.0 |
| 5-year dividend growth rate | -16.79 | -16.79 | 1.0 |
| Years of dividend increase | 1.00 | 1.00 | 2.0 |
| Weighted average score | 3.5 | ||
Negative projected free cash flow
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Medium | 6.0 |
| Intangible assets | Wide | 8.0 |
| Switching costs | Medium | 7.0 |
| Network effect | Narrow | 3.0 |
| Economies of scale | Medium | 7.0 |
| Weighted average score | 6.2 | |